Usage, method and reagent case for prediction of cardio-cerebrovascular disease occurrence by polymorphism site genetype
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ANHUI PROV INST OF BIOLOGICAL MEDICINE
- Publication Date
- 2008-01-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention relates to the use of the polymorphic site genotype of the methylenetetrahydrofolate reductase (MTHFR) gene for predicting the occurrence and prognosis of cardiovascular and cerebrovascular diseases. The invention also relates to a method and a kit for predicting the occurrence and prognosis of cardiovascular and cerebrovascular diseases by measuring the genotype of the polymorphic site of the MTHFR gene. The invention belongs to the field of medicine. Background technique
[0002] Stroke has four characteristics of high incidence, high recurrence rate, high disability rate and high mortality rate, and the treatment methods are limited. It is one of the most serious diseases that endanger human health. Therefore, the prevention of various risk factors is becoming more and more important. important. Risk factors for stroke can be divided into two parts: controllable and uncontrollable. Controllable risk factors are the primary preventio...